Bioceres Crop Solutions C... (BIOX)
Bioceres Crop Solutions Statistics
Share Statistics
Bioceres Crop Solutions has 62.71M shares outstanding. The number of shares has increased by -0.19% in one year.
| 62.71M |
| -0.19% |
| -0.23% |
| 19.93% |
| n/a |
| 4,920 |
| 2.63% |
Short Selling Information
The latest short interest is 888.55K, so 1.47% of the outstanding shares have been sold short.
| 888.55K |
| 1.47% |
| 2.61% |
| 6.99 |
Valuation Ratios
The PE ratio is 215.64 and the forward PE ratio is 24.9. Bioceres Crop Solutions's PEG ratio is -2.6.
| 215.64 |
| 24.9 |
| 1.5 |
| 0.5 |
| 2.23 |
| 36.94 |
| -2.6 |
Enterprise Valuation
Bioceres Crop Solutions has an Enterprise Value (EV) of 925.88M.
| 1.99 |
| 16.7 |
| 22.19 |
| 48.9 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.86.
| 1.24 |
| 0.86 |
| 0.86 |
| 4.89 |
| 14.31 |
| 1.67 |
Financial Efficiency
Return on Equity is 1.03% and Return on Invested Capital is 4.23%.
| 1.03% |
| 0.38% |
| 4.23% |
| $1,162,071.37 |
| $8,108.4 |
| 400 |
| 0.55 |
| 2.24 |
Taxes
| 3.78M |
| 37.65% |
Stock Price Statistics
The stock price has increased by -54.44% in the last 52 weeks. The beta is 0.44, so Bioceres Crop Solutions's price volatility has been higher than the market average.
| 0.44 |
| -54.44% |
| 4.47 |
| 6.26 |
| 55.85 |
| 187,188 |
Income Statement
In the last 12 months, Bioceres Crop Solutions had revenue of 464.83M and earned 3.24M in profits. Earnings per share was 0.05.
| 464.83M |
| 181.59M |
| 44.82M |
| 3.24M |
| 55.46M |
| 34.16M |
| 0.05 |
Balance Sheet
The company has 44.47M in cash and 270.95M in debt, giving a net cash position of -226.47M.
| 44.47M |
| 270.95M |
| -226.47M |
| -10.66M |
| 835.2M |
| 94.9M |
Cash Flow
In the last 12 months, operating cash flow was 41.72M and capital expenditures -22.78M, giving a free cash flow of 18.93M.
| 41.72M |
| -22.78M |
| 18.93M |
| 0.3 |
Margins
Gross margin is 39.07%, with operating and profit margins of 9.64% and 0.7%.
| 39.07% |
| 9.64% |
| 2.16% |
| 0.7% |
| 11.93% |
| 9.64% |
| 4.07% |
Dividends & Yields
BIOX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 0.46% |
| 2.71% |
Analyst Forecast
The average price target for BIOX is $7, which is 42% higher than the current price. The consensus rating is "Buy".
| $7 |
| 42% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| $0.26 |
| -94.73% |
| 2.41 |
| -51.12% |
Scores
| 1.11 |
| 5 |